Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02248644

Ligand	Ligand name	Chain	PDB	Tanimoto
OHT	4-HYDROXYTAMOXIFEN	A	3ERT	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	1S9Q	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	1VJB	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B,C,P,R	2JF9	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B,C,D,E,F	2GPV	0.7
OHT	4-HYDROXYTAMOXIFEN	A	2GPU	0.7
OHT	4-HYDROXYTAMOXIFEN	A	2P7Z	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	2BJ4	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	2FSZ	0.7
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1J3F	0.73
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1UFJ	0.73
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1V9Q	0.73
17M	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	A,B	2B1Z	0.71
IFA		A,B	3FC8	0.71
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.76
ECA	N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3-DIHYDROXYBENZAMIDE)	A,B	2CHU	0.73
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.77
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.71
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG2	0.7
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG1	0.7
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RH0	0.7
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGU	0.7
OTS	4-(2S-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGT	0.7
PFL	2,6-BIS(1-METHYLETHYL)PHENOL	A,B	1E7A	0.71
109	2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3C	0.7
109	2-(4-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3E	0.7
4HL	4-(HYDRAZINOMETHYL)PHENOL	A,B	2E2U	0.72
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.74
2E3	(2E)-3-[4-hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]prop-2-enoic acid	A	3FUG	0.71
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.72
108	2-(5-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3B	0.73
108	2-(5-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID	A	1G3D	0.73
A48	4-[(DIMESITYLBORYL)(2,2,2-TRIFLUOROETHYL)AMINO]PHENOL	A,B	2Q6J	0.75
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RGT	0.7
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	1RG2	0.7
OTR	4-(2R-AMINO-1-HYDROXYETHYL)PHENOL	A,B	2AN4	0.7
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.79
AEH	4-(2-aminoethyl)-2-ethylphenol	A	3BUG	0.78
AED	4-(2-aminoethyl)-2-cyclohexylphenol	A	3BUH	0.8
IFB	N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE	A,B	3FCB	0.72
AEG	4-[(2R)-2-aminopropyl]phenol	A	3BUF	0.75
ANF	ANTHRONE	H	2BJM	0.71
1OH	4-(1-methyl-1-phenylethyl)phenol	A	2ZAS	0.75
DES	DIETHYLSTILBESTROL	A,B,C,D	1S9P	0.71
DES	DIETHYLSTILBESTROL	A,B	3ERD	0.71
DES	DIETHYLSTILBESTROL	A,B	1TT6	0.71
DES	DIETHYLSTILBESTROL	A,B,C,D	1TZ8	0.71
AEF	4-(2-aminoethyl)phenol	A	3BRA	0.74
LDP	L-DOPAMINE	A,B	2A3R	0.71
LDP	L-DOPAMINE	A	5PAH	0.71
LDP	L-DOPAMINE	A,B	2QMZ	0.71
LDP	L-DOPAMINE	A,B	2VQ5	0.71
TXF	(Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL	A,B,C,D,E	2EWP	0.7
BS2	(3-ENDO,8-ANTI)-8-BENZYL-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8-AZONIABICYCLO[3.2.1]OCTANE	A,D,E	2W8G	0.7
BPZ	4,4'-cyclohexane-1,1-diyldiphenol	A	2ZKC	0.76
LJ1	2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol	A,B	3CN0	0.74
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.72
2OH	4,4'-PROPANE-2,2-DIYLDIPHENOL	A	2E2R	0.74
2OH	4,4'-PROPANE-2,2-DIYLDIPHENOL	A	2P7G	0.74
843	N-ACETYL-N-[1-(1,1'-BIPHENYL-4-YLMETHYL)-2-OXOAZEPAN-3-YL]-O-PHOSPHONOTYROSINAMIDE	A	1O42	0.72
HXS	4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol	A,B	3CV6	0.73
DPD		A,B	1QIW	0.72
DPD		A	1QIV	0.72
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.77
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.77
AEJ	(1S)-1-{4-[(9AR)-OCTAHYDRO-2H-PYRIDO[1,2-A]PYRAZIN-2-YL]PHENYL}-2-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLIN-6-OL	A,B,C,D	1XQC	0.71
AHT	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	I,T	1TMB	0.73
ARY	ARYLOMYCIN A2	A,B	1T7D	0.71
OI1	3-(4-HYDROXYBENZYL)-2-[1-({[2-(4-HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]-4-OXO-3,6,11,11A-TETRAHYDRO-4H-PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM-1-OLATE	A,B	1Q9D	0.7